ID: ALA293534

Max Phase: Preclinical

Molecular Formula: C19H23NO3

Molecular Weight: 313.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(/C=C/C=C(\C)C(=O)Nc1c(C)cc(C)cc1C)=C\C(=O)O

Standard InChI:  InChI=1S/C19H23NO3/c1-12(11-17(21)22)7-6-8-14(3)19(23)20-18-15(4)9-13(2)10-16(18)5/h6-11H,1-5H3,(H,20,23)(H,21,22)/b7-6+,12-11+,14-8+

Standard InChI Key:  UIUBMZXDAWORTQ-HUJWONBPSA-N

Associated Targets(Human)

Cellular retinoic acid-binding protein I 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoic acid receptor alpha 153 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 313.40Molecular Weight (Monoisotopic): 313.1678AlogP: 4.08#Rotatable Bonds: 5
Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.36CX Basic pKa: CX LogP: 4.63CX LogD: 1.71
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.64Np Likeness Score: 0.54

References

1. Shealy YF, Riordan JM, Frye JL, Simpson-Herren L, Sani BP, Hill DL..  (2003)  Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid.,  46  (10): [PMID:12723955] [10.1021/jm020324t]

Source